Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

2

Revenue 2017

Revlimid

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Revlimid was produced by Celgene.

BMS closes on Celgene merger after rebel investors bow out

BMS closes on Celgene merger after rebel investors bow out News on Revlimid patent also positive. Bristol-Myers Squibb chalked up a morale-boosting victory in its bid to close its $74bn merger with Celgene, after a rebel investment group abandoned ... Both shareholders have said they are concerned about

Celgene hopes for second time lucky for ozanimod FDA filing

Celgene hopes for second time lucky for ozanimod FDA filing One of six key drugs for BMS-Celgene merger

Janssen looks to expand Darzalex in Europe

Janssen looks to expand Darzalex in Europe Regimen reduced risk of disease progression or death by 44%. Janssen is looking to broaden the use of its multiple myeloma blockbuster Darzalex, this time combining it with Celgene’s Revlimid ... Those patients were directly compared to a group taking

NICE partially clears Darzalex combo in blood cancer

NICE partially clears Darzalex combo in blood cancer Notably, 29% of those in one trial arm used Celgene’s Revlimid as their first-line treatment; where as only 12% in the other group used Darzalex. ... Clinical experts stated that there was no evidence to suggest that Revlimid modifies the effect of

BMS trades blows with investor on Celgene deal merits

BMS trades blows with investor on Celgene deal merits The activist investors claim that BMS is buying a company with a massive patent cliff – principally blood cancer blockbuster Revlimid (lenalidomide) – which they say will requite Celgene to replace 60% of

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OUTiCO

Providing an exceptional outsourcing service to the Pharma & Healthcare industries. We offer a sustainable approach and drive sales outcomes...

Latest intelligence

The Exhibition Hall: Past, Present and Future
As I sit here at another pharma conference, I start to reflect on how they have changed over the years....
Success breeds success
This week we received the exciting news that we have been shortlisted for the Times Business Awards 2019, Tunbridge Wells in the 'Best Business 1-25 Employees' category....
Turning learning into action: The challenge of behaviour change
...

Infographics